A novel cell-penetrating peptide TAT-A1 delivers siRNA into tumor cells selectively

Biochimie

Volumn 95, Issue 2, 2013, Pages 251-257

  Fang, Bing ^a   Jiang, Lu ^a   Zhang, Ming ^a   Ren, Fa Zheng ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

A1; Cell penetrating peptide; siRNA; Tumor targeting; Vascular endothelial growth factor receptor 1

Indexed keywords

CELL PENETRATING PEPTIDE; SMALL INTERFERING RNA; TAT A1 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1;

ARTICLE; BINDING ASSAY; CELL CULTURE; CELL STRAIN HEPG2; CELL STRAIN HL 60; CELL STRAIN HT29; CONFOCAL LASER MICROSCOPY; CONFOCAL MICROSCOPE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; POLYMERASE CHAIN REACTION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; RNA ISOLATION; TUMOR CELL; WESTERN BLOTTING;

BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL SURVIVAL; CELL-PENETRATING PEPTIDES; DRUG CARRIERS; GENE EXPRESSION; GENE PRODUCTS, TAT; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (PHOSPHORYLATING); HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIPIDS; MOLECULAR TARGETED THERAPY; ORGAN SPECIFICITY; PEPTIDE FRAGMENTS; RNA, MESSENGER; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84872805989     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2012.09.020     Document Type: Article

References (60)

1. E.J. Sontheimer Assembly and function of RNA silencing complexes Nat. Rev. Mol. Cell. Biol. 6 2005 127 138
2. E. Song, S.K. Lee, J. Wang, N. Ince, N. Ouyang, J. Min, J. Chen, P. Shankar, and J. Lieberman RNA interference targeting Fas protects mice from fulminant hepatitis Nat. Med. 9 2003 347 351
3. M. Sioud, and D.R. Sorensen Cationic liposome-mediated delivery of siRNAs in adult mice Biochem. Biophys. Res. Commun. 312 2003 1220 1225
4. B. Urban-Klein, S. Werth, S. Abuharbeid, F. Czubayko, and A. Aigner RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo Gene Ther. 12 2005 461 466
5. J. Jantscha, N. Turzac, M. Volkea, K.U. Eckardta, M. Henseld, A. Steinkasserer, C. Willama, and A.T. Prechtel Small interfering RNA (siRNA) delivery into murine bone marrow-derived dendritic cells by electroporation J. Immunol. Methods 337 2008 71 77
6. T.R. Brummelkamp, R. Bernards, and R. Agami Stable suppression of tumorigenicity by virus-mediated RNA interference Cancer Cell 2 2002 243 247
7. S.A. Stewart, D.M. Dykxhoorn, D. Palliser, H. Mizuno, E.Y. Yu, D.S. An, D.M. Sabatini, I.S. Chen, W.C. Hahn, P.A. Sharp, R.A. Weinberg, and C.D. Novina Lentivirus-delivered stable gene silencing by RNAi in primary cells RNA 9 2003 493 501
8. F. Carlotti, M. Bazuine, T. Kekarainen, J. Seppen, P. Pognonec, J.A. Maassen, and R.C. Hoeben Lentiviral vectors efficiently transduce quiescentmature 3T3-L1 adipocytes Mol. Ther. 9 2004 209 217
9. M.A. Behlke Progress towards in vivo use of siRNAs Mol. Ther. 13 2006 644 670
10. H. Ma, J. Zhu, M. Maronski, P.T. Kotzbauer, V.M. Lee, M.A. Dichter, and S.L. Diamond Non-classical nuclear localization signal peptides for high efficiency lipofection of primary neurons and neuronal cell lines Neuroscience 112 2002 1 5
11. M.T. McManus, B.B. Haines, C.P. Dillon, C.E. Whitehurst, L. van Parijs, J. Chen, and P.A. Sharp Small interfering RNA-mediated gene silencing in T lymphocytes J. Immunol. 169 2002 5754 5760
12. K.A. Strait, P.K. Stricklett, J.L. Kohan, M.B. Miller, and D.E. Kohan Calcium regulation of endothelin-1 synthesis in rat innermedullary collecting duct Am. J. Physiol. 293 2007 601 606
13. M. Zorko, and U. Langel Cell-penetrating peptides: mechanism and kinetics of cargo delivery Adv. Drug Deliv. Rev. 57 2005 529 545
14. E.L. Snyder, and S.F. Dowdy Cell penetrating peptides in drug delivery Pharm. Res. 21 2004 389 393
15. J.S. Wadia, and S.F. Dowdy Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer Adv. Drug Deliv. Rev. 57 2005 579 596
16. M.J. Gait Peptide-mediated cellular delivery of antisense oligonucleotides and their analogues Cell. Mol. Life Sci. 60 2003 844 853
17. A. Eguchi, T. Akuta, H. Okuyama, T. Senda, H. Yokoi, H. Inokuchi, S. Fujita, T. Hayakawa, K. Takeda, M. Hasegawa, and M. Nakanishi Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells J. Biol. Chem. 276 2001 26204 26210
18. P. Jarver, and U. Langel The use of cell-penetrating peptides as a tool for gene regulation Drug Discov. Today 9 2004 395 402
19. B. Gupta, T.S. Levchenko, and V.P. Torchilin Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides Adv. Drug Deliv. Rev. 57 2005 637 651
20. E. Vives Present and future of cell-penetrating peptide mediated delivery systems: "is the Trojan horse too wild to go only to Troy?" J. Controll. Release 109 2005 77 85
21. N. Svensen, J.G.A. Walton, and M. Bradley Peptides for cell-selective drug delivery Trends Pharmacol. Sci. 33 2012 186 192
22. L.L. Zhang, J.A. Hoffman, and E. Ruoslahti Molecular profiling of heart endothelial cells Circulation 112 2005 1601 1611
23. B.W. Park, H.T. Zhang, C. Wu, A. Berezov, X. Zhang, R. Dua, Q. Wang, G. Kao, D.M. O'Rourke, M.I. Greene, and R. Murali Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo Nat. Biotechnol. 18 2000 194 198
24. H. Myrberg, L. Zhang, M. Mäe, and U. Langel Design of a tumor-homing cell-penetrating peptide Bioconjug. Chem. 19 2008 70 75
25. N. Zhou, Z. Luo, J. Luo, X. Fan, M. Cayabyab, M. Hiraoka, D. Liu, X. Han, J. Pesavento, C.Z. Dong, Y. Wang, J. An, H. Kaji, J.G. Sodroski, and Z. Huang Exploring the stereochemistry of CXCR4-peptide recognition and inhibiting HIV-1 entry with D-peptides derived from chemokines J. Biol. Chem. 277 2002 17476 17485
26. D. Simberg, T. Duza, J.H. Park, M. Essler, J. Pilch, L. Zhang, A.M. Derfus, M. Yang, R.M. Hoffman, S. Bhatia, M.J. Sailor, and E. Ruoslahti Biomimetic amplification of nanoparticle homing to tumors Proc. Natl. Acad. Sci. U. S. A. 104 2007 932 936
27. D. Hanahan, and J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 1996 353 364
28. N. Ferrara, and T. Davis-Smyth Vascular endothelial growth factor as a target for anticancer therapy Endocr. Rev. 18 1997 4 25
29. Z. Zhu, K. Hattori, H. Zhang, X. Jimenez, D.L. Ludwig, S. Dias, P. Kussie, H. Koo, H.J. Kim, D. Lu, M. Liu, R. Tejada, M. Friedrich, P. Bohlen, L. Witte, and S. Rafii Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. correlation between antibody affinity and biological activity Leukemia 17 2003 604 611
30. P. Kunkel, U. Ulbricht, P. Bohlen, M.A. Brockmann, R. Fillbrandt, D. Stavrou, M. Westphal, and K. Lamszus Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2 Cancer Res. 61 2001 6624 6628
31. C. Cao, J.M. Albert, L. Geng, P.S. Ivy, A. Sandler, D.H. Johnson, and B. Lu Vascular endothelial growth factor tyrosine kinase inhibitor AZD2171 and fractionated radiotherapy in mouse models of lung cancer Cancer Res. 66 2006 11409 11415
32. A.F. List Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies Oncologist 6 2001 24 31
33. J.C. Lee, N.H. Chow, S.T. Wang, and S.M. Huang Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients Eur. J. Cancer 36 2000 748 753
34. T. Tokunaga, Y. Oshika, Y. Abe, Y. Ozeki, S. Sadahiro, H. Kijima, T. Tsuchida, H. Yamazaki, Y. Ueyama, N. Tamaoki, and M. Nakamura Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer Br. J. Cancer 77 1998 998 1002
35. W.J. Fairbrother, H.W. Christinger, A.G. Cochran, G. Fuh, C.J. Keenan, C. Quan, S.K. Shriver, J.Y.K. Tom, J.A. Wells, and B.C. Cunningham Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site Biochemistry 37 1998 17754 17764
36. M. El-Mousawi, L. Tchistiakova, L. Yurchenko, G. Pietrzynski, M. Moreno, D. Stanimirovic, D. Ahmad, and V. Alakhov A vascular endothelial growth factor high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display peptide library J. Biol. Chem. 278 2003 46681 46691
37. V. Goncalves, B. Gautier, P. Coric, S. Bouaziz, C. Lenoir, C. Garbay, M. Vidal, and N. Inguimbert Rational design, structure, and biological evaluation of cyclic peptides mimicking the vascular endothelial growth factor J. Med. Chem. 50 2007 5135 5146
38. A.D. Frankel, and C.O. Pabo Cellular uptake of the tat protein from human immunodeficiency virus Cell 55 1988 1189 1193
39. E.L. Snyder, C.C. Saenz, C. Denicourt, B.R. Meade, X.S. Cui, I.M. Kaplan, and S.F. Dowdy Enhanced targeting and killing of tumor cells expressing the CXC chemokine receptor 4 by transducible anticancer peptides Cancer Res. 65 2005 10646 10650
40. S.E. Perea, O. Reyes, Y. Puchades, O. Mendoza, N.S. Vispo, I. Torrens, A. Santos, R. Silva, B. Acevedo, E. López, V. Falcón, and D.F. Alonso Antitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2) Cancer Res. 64 2004 7127 7129
41. J.S. Wadia, R.V. Stan, and S.F. Dowdy Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis Nat. Med. 10 2004 310 315
42. I.N. Shokolenko, M.F. Alexeyev, S.P. LeDoux, and G.L. Wilson Tat-mediated protein transduction and targeted delivery of fusion proteins into mitochondria of breast cancer cells DNA Repair (Amst) 4 2005 511 518
43. D.M. Theisen, C. Pongratz, K. Wiegmann, F. Rivero, O. Krut, and M. Krönke Targeting of HIV-1 Tat traffic and function by transduction- competent single chain antibodies Vaccine 24 2006 3127 3136
44. L. Cao, J. Si, W. Wang, X. Zhao, X. Yuan, H. Zhu, X. Wu, J. Zhu, and G. Shen Intracellular localization and sustained prodrug cell killing activity of TAT-HSVTK fusion protein in hepatocelullar carcinoma cells Mol. Cells 21 2006 104 111
45. J.J. Turner, A.A. Arzumanov, and M.J. Gait Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides Nucleic Acids Res. 33 2005 27 42
46. J.J. Turner, G.D. Ivanova, B. Verbeure, D. Williams, A.A. Arzumanov, S. Abes, B. Lebleu, and M.J. Gait Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells Nucleic Acids Res. 33 2005 6837 6849
47. T. Shiraishi, S. Pankratova, and P.E. Nielsen Calcium ions effectively enhance the effect of antisense peptide nucleic acids conjugated to cationic Tat and oligoarginine peptides Chem. Biol. 12 2005 923 929
48. T. Shiraishi, and P.E. Nielsen Photochemically enhanced cellular delivery of cell penetrating peptide-PNA conjugates FEBS Lett. 580 2006 1451 1456
49. Y.L. Chiu, A. Ali, C.Y. Chu, H. Cao, and T.M. Rana Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells Chem. Biol. 11 2004 1165 1175
50. N. Unnamalai, B.G. Kang, and W.S. Lee Cationic oliopeptide-mediated delivery of dsRNA for post-transcriptional gene silencing in plant cells FEBS Lett. 566 2004 307 310
51. F. Simeoni, M.C. Morris, F. Heitz, and G. Divita Insight into the mechanism of peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells Nucleic Acids Res. 31 2003 2717 2724
52. M. Tan, K.H. Lan, J. Yao, C.H. Lu, M. Sun, C.L. Neal, J. Lu, and D. Yu Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide Cancer Res. 66 2006 3764 3772
53. M.W. Pfaffl, G.W. Horgan, and L. Dempfle Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR Nucleic Acids Res. 30 2002 e36
54. S.R. Schwarze, K.A. Hruska, and S.F. Dowdy Protein transduction: unrestricted delivery into all cells Trends Cell Biol. 10 2000 290 295
55. W.M. Yau, W.C. Wimley, K. Gawrisch, and S.H. White The preference of tryptophan for membrane interfaces Biochemistry 37 1998 14713 14718
56. S. Persson, J.A. Killian, and G. Lindblom Molecular ordering of interfacially localized tryptophan analogs in ester- and ether-lipid bilayers studied by H-2-NMR Biophys. J. 75 1998 1365 1371
57. J.A. Killian, I. Salemink, M.R.R. de Planque, G. Lindblom, R.E. Koeppe, and D.V. Greathouse Induction of nonbilayer structures in diacylphosphatidylcholine model membranes by transmembrane alpha-helical peptides: importance of hydrophobic mismatch and proposed role of tryptophans Biochemistry 35 1996 1037 1045
58. F.N. Petersen, M.O. Jensen, and C.H. Nielsen Interfacial tryptophan residues: a role for the cation-pi effect Biophys. J. 89 2005 3985 3996
59. S.R. Schwarze, A. Ho, A. Vocero-Akbani, and S.F. Dowdy In vivo protein transduction: delivery of a biologically active protein into the mouse Science 285 1994 1569 1572
60. M. Hallbrink, A. Floren, A. Elmquist, M. Pooga, T. Bartfai, and U. Langel Cargo delivery kinetics of cell-penetrating peptides Biochim. Biophys. Acta 1515 2001 101 109